Plus   Neg

VF Corp. Reaffirms 2020 Outlook; Raises Dividend - Quick Facts

VF Corp. (VFC) said, for fiscal 2020, the company continues to project revenue to approximate $11.8 billion, reflecting an increase of approximately 6 percent (8 percent on a constant dollar basis excluding the impact of acquisitions and divestitures). Adjusted earnings per share is still expected to be in the range of $3.32 to $3.37, reflecting growth of approximately 16 percent to 18 percent (19
percent to 21 percent on a constant dollar basis, excluding acquisitions and divestitures). Analysts polled by Thomson Reuters expect the company to report profit per share of $3.39 on revenue of $11.87 billion. Analysts' estimates typically exclude special items.

For the third-quarter, on an adjusted basis, earnings per share increased 6 percent (up 8 percent in constant dollars) to $1.26. On average, 21 analysts polled by Thomson Reuters expected the company to report profit per share of $1.31, for the quarter.

Third-quarter revenue increased 5 percent (up 7 percent in constant dollars) to $3.39 billion. Excluding the impact of acquisitions and divestitures and on an adjusted basis, revenue increased 6 percent (up 8 percent in constant dollars). Analysts expected revenue of $3.42 billion for the quarter.

VF's Board declared a quarterly dividend of $0.48 per share, a 12 percent increase over the previous quarter's dividend. The dividend will be payable on December 20, 2019, to shareholders of record on December 10, 2019.

Shares of VF Corp. were down 13% in pre-market trade on Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla has cut prices of its electric cars in North America following a decline in auto demand during the coronavirus-induced lockdowns. The company is also reducing the prices for its vehicles in China. The luxury electric car maker has reduced the prices for its flagship Model S sedan and the Model X sport utility vehicle by $5,000 each. The U.S. Food and Drug Administration granted approval for Artesunate for Injection 110 mg, powder and solvent for solution to biopharmaceutical company Amivas (US), LLC as the only FDA-approved drug now in the U.S. for the first-line treatment of severe malaria in adult and pediatric patients. It is also the first FDA-approved product that Amivas has introduced to their commercial portfolio. Retail giant Walmart Inc. is entering the fashion resale market through its partnership with thredUP, an online consignment store for second-hand fashion and accessories. The deal will enable Walmart to expand its online fashion offerings. Walmart said that starting Wednesday, customers can browse nearly 750,000 pre-owned items across women's and children's clothing, accessories and footwear.
Follow RTT